Brain-dwelling worm in UK man's head sequenced

Tapeworm removed from UK resident's brain reveals genetic secrets of an elusive Far East parasite

Brain-dwelling worm in UK man's head sequenced

141121-brainworm.pngGenome Biology 2014, 15: 510
Over the course of four years, the worm from migrated 5cm from the right side of the brain to the left, as shown by the cluster of ring-enhancing lesions the larvae produced.

For the first time, the genome of a rarely seen tapeworm has been sequenced. The genetic information of this invasive parasite, which lived for four years in a UK resident's brain, offers new opportunities to diagnose and treat this invasive parasite.

The tapeworm, Spirometra erinaceieuropaei, has been reported only 300 times worldwide since 1953 and has never been seen before in the UK. The worm causes sparganosis: inflammation of the body's tissues in response to the parasite. When this occurs in the brain, it can cause seizures, memory loss and headaches. The worm's rarity means that little is known about its complex lifecycle and biology, however it is thought that people may be infected by accidently consuming tiny infected crustaceans from lakes, eating raw meat from reptiles and amphibians, or by using a raw frog poultice - a Chinese remedy to calm sore eyes.

Before the 1cm-long parasite was diagnosed and successfully removed by surgery, it had travelled 5cm from the right side of the brain to the left. The tapeworm was placed on a histology slide by the hospital to confirm the clinical diagnosis. The patient is now systemically well.

"The clinical histology slide offered us a great opportunity to generate the first genome sequence of this elusive class of tapeworms. However, we only had a minute amount of DNA available to work with - just 40 billionths of a gram. So we had to make difficult decisions as to what we wanted to find out from the DNA we had."

Dr Hayley Bennett, first author of the study from the Wellcome Trust Sanger Institute

To identify the exact species of worm, the researchers sequenced one particular gene, the so-called 'barcode of life'. Fortunately for the patient, the gene's DNA sequence revealed that the parasite was the more benign of the two sparganosis-causing worm species. Remarkably, the team also were able to generate sufficient DNA sequence data using standard next-generation sequencing techniques to piece together a draft genome. This is now being used to investigate known and potential treatment targets, which may help patients in the future.

"We did not expect to see an infection of this kind in the UK, but global travel means that unfamiliar parasites do sometimes appear. We can now diagnose sparganosis using MRI scans, but this does not give us the information we need to identify the exact tapeworm species and its vulnerabilities. Our work shows that, even with only tiny amounts of DNA from clinical samples, we can find out all we need to identify and characterise the parasite."

Dr Effrossyni Gkrania-Klotsas, study author from the Department of Infectious Disease, Addenbrooke's NHS Trust

"This emphasises just how important a global database of worm genomes is to allow us to identify the parasite and determine the best course of treatment. Additionally, this information can be paired with our work in global travellers' infection to give additional insights in what infections other patients can get in specific destinations. We are really lucky to be able to work closely with such an excellent facility as the Wellcome Trust Sanger Institute."

Spirometra erinaceieuropaei's genome is 1.26Gb long, making it ten times larger than other tapeworm genomes and one-third the size of the human genome. Some of this seems to come from an increase in the number of genes that may help the parasite to break up proteins and invade its host, coupled with the fact that the genome is much more repetitive than other tapeworm genomes.

The team also used this draft sequence to look for similarities and differences from other, previously sequenced, tapeworm species in the GeneDB pathogen database. This has revealed more about Spirometra erinaceieuropaei's biology than ever before. For example, the worm has a large selection of molecular motors for moving proteins around the cell, which could underpin the large changes in body shape and environmental adaptions that the worm undergoes during its complicated lifecycle.

"For this uncharted group of tapeworms, this is the first genome to be sequenced and has allowed us to make some predictions about the likely activity of known drugs. The genome sequence suggests that the parasite is naturally resistant to albendazole - an existing anti-tapeworm drug. However, many new drug targets that are being explored for other tapeworms are present in this parasite and could offer future clinical possibilities."

Dr Matt Berriman, senior author and member of Faculty of the Sanger Institute

Because such an elusive worm is rare, discovering targets in the genome to existing licensed drugs could prove to be the best way to treat this rare disease. These data contribute to the growing global database for identifying parasites and parasite provenance and will serve as a resource for identifying new treatments for sparganosis.

Notes to Editors
Publications
  • The genome of the sparganosis tapeworm Spirometra erinaceieuropaei isolated from the biopsy of a migrating brain lesion.

    Bennett HM, Mok HP, Gkrania-Klotsas E, Tsai IJ, Stanley EJ et al.

    Genome biology 2014;15;11;510

Selected Websites
Contact the Press Office

Dr Samantha Wynne, Media Officer

Tel +44 (0)1223 492 368

Emily Mobley, Media Officer

Tel +44 (0)1223 496 851

Wellcome Sanger Institute,
Hinxton,
Cambridgeshire,
CB10 1SA,
UK

Mobile +44 (0) 7900 607793

Recent News

Low doses of radiation promote cancer-capable cells
New research in mice helps to understand the risks around exposure to low doses of radiation, such as CT scans and x-rays
Chan Zuckerberg Initiative boosts Human Cell Atlas research at the Sanger Institute
Seed Networks projects will focus on specific tissues, such as the thymus, lung, liver, kidney and immune system
Widely-available antibiotics could be used in the treatment of ‘superbug’ MRSA
Genomic analysis shows that a significant number of strains are susceptible to penicillin combined with clavulanic acid